Shopping Cart 0
Cart Subtotal
AED 0

OncoTherapy Science Inc (4564) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and development activities to develop its anti-cancer drug by providing technology platforms that include laser micro-beam microdissection, cDNA microarray and identification of target genes. The company partners with other healthcare industries to test and develop vaccines for increasing the efficiency of treating cancer. It holds interest in genome analysis of liquid biopsy, cancer and immunotherapy including development of neoantigen prediction. OncoTherapy is headquartered in Kawasaki, Japan.

OncoTherapy Science Inc (4564)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11

OncoTherapy Science and Theragen Etex to Form Joint Venture 12

OncoTherapy Science and Tella Enter into Co-Development Agreement 13

OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14

Licensing Agreements 15

Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15

Equity Offering 16

OncoTherapy Science Prices Private Placement Of Shares For USD 12.7 Million 16

OncoTherapy Science Announces Public Offering Of Shares For USD 102.8 Million 17

OncoTherapy Science Inc-Key Competitors 18

OncoTherapy Science Inc-Key Employees 19

OncoTherapy Science Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 20

Recent Developments 21

Product News 21

Aug 08, 2018: OncoTherapy: Publication of a paper on the development of small molecule compounds inhibiting a novel anti-cancer drug target 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OncoTherapy Science Inc, Deals By Therapy Area, 2012 to YTD 2018 8

OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11

OncoTherapy Science and Theragen Etex to Form Joint Venture 12

OncoTherapy Science and Tella Enter into Co-Development Agreement 13

OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14

Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15

OncoTherapy Science Prices Private Placement Of Shares For USD 12.7 Million 16

OncoTherapy Science Announces Public Offering Of Shares For USD 102.8 Million 17

OncoTherapy Science Inc, Key Competitors 18

OncoTherapy Science Inc, Key Employees 19

OncoTherapy Science Inc, Subsidiaries 20

OncoTherapy Science Inc, Joint Venture 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

OncoTherapy Science Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

OncoTherapy Science Inc (OncoTherapy) is a biotechnology company that discovers and develops antibody drugs for treating cancer. The company offers products under antibodies, cancer vaccines and small molecule drugs. It provides contract research services. OncoTherapy conducts research and development activities to develop its anti-cancer drug by providing technology platforms that include laser micro-beam microdissection, cDNA microarray and identification of target genes. The company partners with other healthcare industries to test and develop vaccines for increasing the efficiency of treating cancer. It holds interest in genome analysis of liquid biopsy, cancer and immunotherapy including development of neoantigen prediction. OncoTherapy is headquartered in Kawasaki, Japan.

OncoTherapy Science Inc (4564)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11

OncoTherapy Science and Theragen Etex to Form Joint Venture 12

OncoTherapy Science and Tella Enter into Co-Development Agreement 13

OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14

Licensing Agreements 15

Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15

Equity Offering 16

OncoTherapy Science Prices Private Placement Of Shares For USD 12.7 Million 16

OncoTherapy Science Announces Public Offering Of Shares For USD 102.8 Million 17

OncoTherapy Science Inc-Key Competitors 18

OncoTherapy Science Inc-Key Employees 19

OncoTherapy Science Inc-Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Joint Venture 20

Recent Developments 21

Product News 21

Aug 08, 2018: OncoTherapy: Publication of a paper on the development of small molecule compounds inhibiting a novel anti-cancer drug target 21

Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22


List Of Figure

List of Figures

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

OncoTherapy Science Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

OncoTherapy Science Inc, Deals By Therapy Area, 2012 to YTD 2018 8

OncoTherapy Science Inc, Medical Devices Deals, 2012 to YTD 2018 9

OncoTherapy Science Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

OncoTherapy Science to Enter into Collaboration Agreement with Osaka Cancer Immuno-Chemotherapy Clinic, Fukuoka General Cancer Clinic, Biothera Clinic 11

OncoTherapy Science and Theragen Etex to Form Joint Venture 12

OncoTherapy Science and Tella Enter into Co-Development Agreement 13

OncoTherapy Science Enters Into Co-Development Agreement With Acronet 14

Shionogi Enters Into Licensing Agreement With OncoTherapy Science For Cancer Peptide Vaccines 15

OncoTherapy Science Prices Private Placement Of Shares For USD 12.7 Million 16

OncoTherapy Science Announces Public Offering Of Shares For USD 102.8 Million 17

OncoTherapy Science Inc, Key Competitors 18

OncoTherapy Science Inc, Key Employees 19

OncoTherapy Science Inc, Subsidiaries 20

OncoTherapy Science Inc, Joint Venture 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

OncoTherapy Science Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.